Trius and General Market Commentary 6/5/13.. Answering critics and explaining market cap to price. Business basics as well.
Tag: stocks
Trius Therapeutics: The Next Big Small-Cap Biotech Mover?
Normally, I write about biotech companies with near-term catalysts I feel offer traders good long based trade opportunities heading into these catalysts. Every so often, I find a small cap biotech where I feel a speculation investment is truly warranted.…
Long Trade Call: Five Star Quality Care Inc. $FVE
Five Star Quality Care, Inc(FVE) is a national healthcare and senior living provider, offers the highest quality of care and service. Five Star has two major operating divisions: Five Star Senior Living and Five Star Rehabilitation Services. The Five Star Senior…
Mannkind Thesis – Bearish $MNKD
In my opinion, investors need to be careful of the current MNKD stock run up. It’s likely it’s manipulation being pulled off by the warrant holders in order for them to cash out with good profit. Company has ZERO chance…
Amarin Basic Company Thesis – Bearish 5/25/13 $AMRN
My basic opinion on Amarin. Like Vascepa, hate management and company structure. My opinion long term is bearish.
Biosciences Delivery Systems+ Antares Chart Update: 5/25/13 $BDSI, $ATRS
My opinion on Antares BDSI pasy trading action and for the future.
I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.
BioDelivery Sciences (BDSI) focuses on developing and commercializing products in the areas of pain management and oncology supportive care. The company uses its patented BioErodible MucoAdhesive (BEMA) and Bioral cochleate drug delivery technologies in the development of its products. …
Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed
The Orphan Drug Act was passed in January 1983 to encourage companies to develop drugs that treat rare medical conditions. Companies that receive Orphan Drug Status gain certain financial incentives such as a longer period of exclusivity, enhanced patent protection,…
Updated: Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy
Today, we are going to take a comprehensive look at a small-cap biotech company with several near-term catalysts, a strong cash position, and high insider ownership. I feel with all factors considered, this company can see very good price appreciation…
Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks.
Sadly, terrorism is a real threat to the United States homeland as we just saw last week. However, we can take a little solace in the fact that the recent terrorist attack involved crude homemade non-radiological bombs. The fact remains…
